title: Anti-TNF-α therapy itself does not trigger Guillain-Barré syndrome.
authors.forename: B R
authors.initials: BR
authors.lastname: Wakerley
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Yuki
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D020275:Guillain-Barre Syndrome / Q000139:chemically induced*; D006801:Humans; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents